PT Merck Tbk
IDX:MERK.JK
3,690 (IDR) • At close October 30, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | PT Merck Tbk |
Symbool | MERK.JK |
Munteenheid | IDR |
Prijs | 3,700 |
Beurswaarde | 1,657,600,000,000 |
Dividendpercentage | 7.94% |
52-weken bereik | 3,670 - 4,550 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Ms. Evie Yulin |
Website | https://www.merckgroup.com/id-id |
An error occurred while fetching data.
Over PT Merck Tbk
PT Merck Tbk manufactures and sells pharmaceutical products in Indonesia. It operates through three segments: Biopharma, Consumer Health, and Others. It offers health care products in the areas of cardiovascular, metabolic, oncology, endocrinology, fertility, and neurodegenerative diseases, as well as general medicines. The company also engages in discovering, developing, manufacturing,
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (IDR)
Cijfers zijn in miljoenen (IDR)